Mark Lazenby, PhD, APRN, FAPOS, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses psychosocial topics that concern APOS.
Mark Lazenby, PhD, APRN, FAPOS, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses psychosocial topics that concern APOS.
Topics that currently concern researchers align well with the accreditation standards of the Commission on Cancer (CoC), Lazenby says, and include survivorship care plans, navigation, and distress screening.
A lot of science has been presented on the outcomes of distress screening, the importance of validated tools with established cut-off scores, and utilizing the screening to identify people with chronic distress.
Another large part of the science is opening communication between patients and providers, which can be done through survivorship care plans.
Sintilimab Plus Chemoradiotherapy Improves pCR Rate in Resectable, Locally Advanced ESCC
Tislelizumab Plus Chemo Demonstrates Activity and Tolerability in Advanced Gastric/GEJ Cancer
Trastuzumab Combo Shows Numerical Survival Benefit in Gastric/GEJ Cancer
Telotristat Ethyl Plus Chemo May Stabilize Weight in Metastatic PDAC
2 Commerce Drive
Cranbury, NJ 08512